Neuropathology Market Research Report By Diagnosis (Biopsy, Body Fluids, Peripheral Blood Smears, others), Application (Cerebral Hypoxia & Stroke, Perinatal Disorders, CNS Infections, Demyelinative Diseases, others), End User– Global Forecast till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Neuropathology Market, by Diagnosis Test

6.1 Introduction

6.2 Biopsy

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Body fluids

6.3.1 Market Estimates & Forecast, 2020 – 2027

6.4 Peripheral blood smears

6.4.1 Market Estimates & Forecast, 2020 – 2027

6.5 Biopsy

6.5.1 Market Estimates & Forecast, 2020 – 2027

6.6 Tissue resections

6.6.1 Market Estimates & Forecast, 2020 – 2027

6.7 Others

6.7.1 Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Neuropathology Market, by Application

7.1 Introduction

7.2 Cerebral hypoxia and stroke

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 Perinatal disorders

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 CNS infections

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Demyelinative diseases

7.5.1 Market Estimates & Forecast, 2020 – 2027

7.6 Brain tumors

7.6.1 Market Estimates & Forecast, 2020 – 2027

7.7 Neurodegenerative diseases

7.7.1 Market Estimates & Forecast, 2020 – 2027

7.8 Inherited metabolic disorders

7.8.1 Market Estimates & Forecast, 2020 – 2027

7.9 Peripheral neuropathy

7.9.1 Market Estimates & Forecast, 2020 – 2027

7.10 Myopathology

7.10.1 Market Estimates & Forecast, 2020 – 2027

7.11 Others

Chapter 8. Global Neuropathology Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Clinics

8.3.1 Market Estimates & Forecast, 2020 – 2027

8.4 Research centers

8.4.1 Market Estimates & Forecast, 2020 – 2027

8.5 Others

8.5.1 Market Estimates & Forecast, 2020 – 2027

Chapter .9 Global Neuropathology Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Therapath LLC

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 ARUP Laboratories

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Laboratory Corporation of America Holdings

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 F. Hoffmann-La Roche Ltd

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Danaher Corporation

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Quest Diagnostics Incorporated

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 NeoGenomics Laboratories

11.8.1 Company Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Overview

11.8.4 Key Development

11.8.5 SWOT Analysis

11.9 Agilent Technologies Inc.

11.9.1 Company Overview

11.9.2 Product Overview

11.9.3 Financial overview

11.9.4 Key Developments

11.10 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Neuropathology Industry Synopsis, 2020 – 2027

Table 2 Neuropathology Market Estimates and Forecast, 2020 – 2027, (USD Million)

Table 3 Neuropathology Market by Region, 2020 – 2027, (USD Million)

Table 4 Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 5 Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 6 Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 7 North America Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 8 North America Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 9 North America Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 10 US Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 11 US Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 12 US Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 13 Canada Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 14 Canada Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 15 Canada Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 16 South America Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 17 South America Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 18 South America Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 19 Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 20 Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 21 Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 22 Western Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 23 Western Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 24 Western Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 25 Eastern Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 26 Eastern Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 27 Eastern Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 28 Asia Pacific Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 29 Asia Pacific Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 30 Asia Pacific Neuropathology Market by End Users, 2020 – 2027, (USD Million)

Table 31 Middle East & Africa Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)

Table 32 Middle East & Africa Neuropathology Market by Treatment, 2020 – 2027, (USD Million)

Table 33 Middle East & Africa Neuropathology Market by End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Neuropathology Market

Figure 3 Segmentation Market Dynamics for Neuropathology Market

Figure 4 Global Neuropathology Market Share, by Diagnosis 2020

Figure 5 Global Neuropathology Market Share, by Treatment 2020

Figure 6 Global Neuropathology Market Share, by End Users, 2020

Figure 7 Global Neuropathology Market Share, by Region, 2020

Figure 8 North America Neuropathology Market Share, by Country, 2020

Figure 9 Europe Neuropathology Market Share, by Country, 2020

Figure 10 Asia Pacific Neuropathology Market Share, by Country, 2020

Figure 11 Middle East & Africa Neuropathology Market Share, by Country, 2020

Figure 12 Global Neuropathology Market: Company Share Analysis, 2020 (%)

Figure 13 Abbott Laboratories.: Key Financials

Figure 14 Abbott Laboratories, Inc.: Segmental Revenue

Figure 15 Abbott Laboratories.: Geographical Revenue

Figure 16 Therapath LLC: Key Financials

Figure 17 Therapath LLC: Segmental Revenue

Figure 18 Therapath LLC: Geographical Revenue

Figure 19 ARUP Laboratories: Key Financials

Figure 20 ARUP Laboratories: Segmental Revenue

Figure 21 ARUP Laboratories: Geographical Revenue

Figure 22 Laboratory Corporation of America Holdings: Key Financials

Figure 23 Laboratory Corporation of America Holdings: Segmental Revenue

Figure 24 Laboratory Corporation of America Holdings: Geographical Revenue

Figure 25 F. Hoffmann-La Roche Ltd: Key Financials

Figure 26 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 27 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 28 Danaher Corporation: Key Financials

Figure 29 Danaher Corporation: Segmental Revenue

Figure 30 Danaher Corporation: Geographical Revenue

Figure 31 Quest Diagnostics Incorporated: Key Financials

Figure 32 Quest Diagnostics Incorporated: Segmental Revenue

Figure 33 Quest Diagnostics Incorporated: Geographical Revenue

Figure 34 NeoGenomics Laboratories: Key Financials

Figure 35 NeoGenomics Laboratories: Segmental Revenue

Figure 36 NeoGenomics Laboratories: Geographical Revenue

Figure 37 Agilent Technologies Inc: Key Financials

Figure 38 Agilent Technologies Inc: Segmental Revenue

Figure 39 Agilent Technologies Inc: Geographical Revenue